NCT05643521

Brief Summary

The primary aim of this study is to investigate the acute changes in liver fat content in response to a fixed carbohydrate restriction (i.e. intake of 60g/day or 70g/day for women and men, respectively) in individuals with obesity. This will be performed both as 2 days of very low calorie diet (500 and 600 kcal/day for women and men, respectively) and 2 days of eucaloric low carbohydrate diet.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

December 8, 2022

Status Verified

December 1, 2022

Enrollment Period

1.9 years

First QC Date

November 22, 2022

Last Update Submit

December 1, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is the 1H-Magnetic Resonance Spectroscopy (MRS) determined liver TG content.

    We will compare MRS of liver TG after each of the two interventions (2 days of VLCD or 2 days of LC) with MRS liver TG obtained after 2 days of eucaloric conventional diet.

    After 2 days completion of dietary intervention

Secondary Outcomes (1)

  • Secondary outcomes are fasting and postprandial plasma glucose, insulin, and plasma TG concentrations after 2 days VLCD or LC compared with 2 days of eucaloric conventional diet.

    After 2 days completion of dietary intervention

Other Outcomes (1)

  • Explorative outcomes

    After 2 days completion of dietary intervention

Study Arms (3)

Control Arm

EXPERIMENTAL

2 days of eucaloric control diet prior to MRS estimating liver fat (control arm)

Other: Dietary composition of macronutrients and calories

Hypocaloric low carbohydrate

EXPERIMENTAL

2 days of eucaloric control diet + 2 days of hypocaloric (500-600 kcal m/f) low carbohydrate diet prior to liver fat estimated by MRS and metabolic testday.

Other: Dietary composition of macronutrients and calories

Eucaloric low carbohydrate

EXPERIMENTAL

2 days of eucaloric control diet + 2 days of eucaloric low carbohydrate diet prior to liver fat estimated by MRS and metabolic testday.

Other: Dietary composition of macronutrients and calories

Interventions

Carbohydrate restriction

Control ArmEucaloric low carbohydrateHypocaloric low carbohydrate

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men (30-75 years) and postmenopausal women 45-75 years old
  • Hba1c \<48 mmol/mol without antidiabetic treatment
  • Obese (BMI 27-40 kg/m2)
  • Non smokers

You may not qualify if:

  • Anemia (hemoglobin \<8 mmol/L for men and \<7 mmol/L for women)
  • TSH outside reference range
  • Medication known to influence glucose metabolism or appetite regulation
  • Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner, pacemaker or other electronic device implanted, implanted metal devices, severe claustrophobia
  • Food allergies (including lactose and gluten intolerance), vegetarian/vegan diet or following specific dietary plans
  • Alcohol consumptions \>84/168 g/week (women/men)
  • Strenuous activity level \> 120 minutes per week
  • \>5 kg weight loss within the last three months or previous bariatric surgery
  • High risk of fibrosis of the liver (estimated by FIB4 score \> 3,25)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Non-alcoholic Fatty Liver DiseaseOverweightObesityMetabolic SyndromeDiabetes Mellitus

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Crossover Assignment Randomized diet intervention study in a cross over design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, MD, PhD Affiliation: Hvidovre University Hospital

Study Record Dates

First Submitted

November 22, 2022

First Posted

December 8, 2022

Study Start

December 1, 2022

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

December 8, 2022

Record last verified: 2022-12